Cynthia Fleck to Lead Marketing and Clinical Resource Development for Viniferamine® Medical Skin and Wound Care Products - 19 Action News|Cleveland, OH|News, Weather, Sports

Cynthia Fleck to Lead Marketing and Clinical Resource Development for Viniferamine® Medical Skin and Wound Care Products

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Viniferamine

CORALVILLE, Iowa, July 21, 2014 /PRNewswire/ -- Cynthia Fleck, RN, BSN, MBA has joined Viniferamine®, Inc. to expand its marketing and clinical efforts into the skin and wound care markets. Ms. Fleck is the former Vice President of Clinical Marketing for Medline Industries.  Her responsibilities in that position included the launch of Dr. McCord's Olivamine® skin care products.  She brought the Olivamine® brand from zero to 40% market share in less than six years and grew the brand at a rate greater than 25% per year. "I am looking forward to working with Ms. Fleck again as we launch my newest product line into the skin and wound care market," stated Dr. McCord.

McCord Research.

Ms. Fleck has been very involved in skin and wound care for many years.  Some of her accomplishments include past President and Chairman of the American Board of Wound Management (ABWM), past two-term board member of the Association for the Advancement of Wound Care (AAWC), and Director of the American College of Clinical Wound Specialists.  Further, she has presented over 500 skin and wound care seminars throughout the world and authored over 250 articles and manuscripts in the field for various peer reviewed and clinical publications.

"We have brought a team of clinical and marketing experts together to assist in the launch of the Viniferamine® brand. Ms. Fleck is a critical part of the team and I am very pleased that she has agreed to help us expand our marketing and clinical efforts.  She is a great team player and she is well known as a top expert in the field," continued Dr. McCord.

The Viniferamine® products were developed at McCord Research under the direction of Dr. McCord and they are distributed exclusively by NDC, the company's logistic partner.  The product line includes topical OTC creams, antiseptics, cleansers and wound hydrogels that are governed by the FDA's medical device registration criteria.

For more information about the Viniferamine product line or for ordering information, please visit the Viniferamine website.

Websites
www.viniferamine.com
www.mccordresearch.com

Social Media
www.facebook.com/Viniferamine

Contact - Kate Stensland, 319-351-3201

Logo - http://photos.prnewswire.com/prnh/20120510/CG05130LOGO

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow